| Sivakoti Nagireddy Guda, MD | |
|
1600 Haddon Ave Fl 6, Camden, NJ 08103-3101 | |
| (856) 757-3500 | |
| Not Available |
| Full Name | Sivakoti Nagireddy Guda |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 1600 Haddon Ave Fl 6, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013043520 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
| Vitas Healthcare Corporation Atlantic | Livingston, NJ | Hospice |
| Samaritan Healthcare And Hospice | Marlton, NJ | Hospice |
| Roxborough Memorial Hospital | Philadelphia, PA | Hospital |
| Suburban Community Hospital | Norristown, PA | Hospital |
| Temple University Hospital | Philadelphia, PA | Hospital |
| Carepoint Health-christ Hospital | Jersey city, NJ | Hospital |
| Masonic Village At Burlington | Burlington, NJ | Nursing home |
| Lafayette-redeemer, The | Philadelphia, PA | Nursing home |
| St Joseph's Manor (dba Entity Of Hrhs) | Meadowbrook, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Garden State Healthcare Associates Llc | 8426190687 | 149 |
| Inhospital Physicians Corp Of New Jersey, Pc | 2264781780 | 28 |
| Inhospital Physicians Corp | 3779888110 | 14 |
| Temple Physicians Inc | 2062317233 | 127 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Mission Hospitalists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629325196 PECOS PAC ID: 4183873359 Enrollment ID: O20121003000260 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Entity Name | Inhospital Physicians Corp Of New Jersey, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336625425 PECOS PAC ID: 2264781780 Enrollment ID: O20180816002176 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sivakoti Nagireddy Guda, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Sivakoti Nagireddy Guda, MD 1600 Haddon Ave Fl 6, Camden, NJ 08103-3101 Ph: (856) 757-3500 |
News Archive
For more than a million patients every year, the burgeoning U.S. hospice industry offers the possibility of a peaceful death, typically at home.
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
Elements and their compounds will no longer be able to hide in mixtures, even if the latter are made up of many components.
InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
› Verified 1 days ago
Dr. Afaf A. Anter, D.O Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Dorrance 222, Camden, NJ 08103 Phone: 856-342-3150 Fax: 856-968-8418 | |
Dr. James Jingren Liu, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Kalpana Thawani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3700 Fax: 856-668-8479 | |
Pratik S Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Dr. Gregory Hilditch, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Okebugwu Kamalu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Maher Al-safadi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 Fax: 856-968-8418 |